Life Sciences Platform

About RapidAI

RapidAI is a leader in deep clinical AI, operating an enterprise platform that provides real-time decision support to over 2,500 hospitals in more than 100 countries. Founded in 2012, the company has a strong foundation in clinical research, with its technology underpinning major trials and boasting 14 FDA-cleared modules. Its solutions focus on high-acuity areas like stroke and pulmonary embolism, aiming to streamline workflows, enhance diagnostic confidence, and improve financial performance for healthcare providers.

Therapeutic Areas